OV logo

The OV-RDT Platform is an innovative solution for screening and managing Opisthorchis Viverrini (liver fluke) infections, a major risk factor for cholangiocarcinoma. Developed by the Cholangiocarcinoma Research Institute and Khon Kaen University, this platform combines mobile technology, artificial intelligence, and data analytics to streamline the screening process and provide valuable insights for public health management.

Components

1. Mobile Application:
- Available on iOS and Android devices
- QR code reader for fast data input
- Camera template for consistent image capture
- AI-powered for reading and image quality control
- Real-time result updates to the dashboard
2. Artificial Intelligence:
- Ensures good image quality
- Locates test strips in images
- Interprets RDT test results with high accuracy (Negative, Level1, Level2, Level3, Level4)
3. Dashboard:
- Comprehensive data visualization
- Metric analysis for epidemic teams
- Geological analysis with multiple granularity levels
- Strategic management tools
- App usage insights for developers

Key Statistics (as of June 10, 2024)

- 103,034 strips screened
- 7,114 registered healthcare professional users
- 41.96% OV positive rate (42,949 people identified for further treatment)
- Used in 21 provinces
- 1,039 participating hospitals and healthcare centers

Benefits

1. Speeds up the screening process
2. Improves data collection and analysis
3. Enables real-time monitoring of OV infection rates
4. Supports strategic public health decision-making
5. Increases accessibility to screening in remote areas

Impacts

- Contributes to early detection of OV infections
- Supports efforts to reduce cholangiocarcinoma incidence
- Provides valuable data for public health research and interventions

Start using
OV-RDT Platform

CVEDIA | CVEDIA-RT
CVEDIA | CVEDIA-RT